Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)
Clinical trial NCT03849313 · COMPLETED
Trial details
- NCT number
- NCT03849313
- Sponsor
- Alvotech Swiss AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-20
- Primary completion
- 2020-02-17
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.